检索结果-南通市图书馆

Short-term and oncological outcomes of natural orifice specimen extraction surgery(NOSES)for colorectal cancer in china:a national database study of 5055 patients

引用

Science Bulletin 2022年第13期67卷 1331-1334,M0003页

作者： Xu Guan Xiyue Hu Zheng Jiang Ye Wei Donghui Sun Miao Wu Haitao Zhou Hongliang Yao Junmin Song Guiyu Wang Junhong Hu Mingyang Ren Qing Xu Jianchun Cai Jian Peng Dan Ma Yangchun Zheng Qingsi He Bo Jiang Zejun Wang Taiyuan Li Su Yan Luchuan Chen Tiegang Li Zhiguo Xiong Pan Chi Liang Kang Gang Yu Xiaodong Deng Hong Zhang Ming Xie Jianbao Wei Hongyan Gong Xuejun Sun Weidong Zang Yongmao Song Peng He Zhengqi Wen Chunxu Zhang Yusheng Wang Yinggang Chen Guangwei Xie Mingzhang Li Shaojun Yu Haiying Liu Min Pu Chuangang Fu Xishan Wang on behalf of china NOSES Alliance department of Colorectal Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China department of General Surgery Zhongshan HospitalFudan UniversityShanghai 200032China department of Gastrointestinal and Anal Surgery Jilin University First HospitalChangchun 130021China department of Gastrointestinal Surgery The Second People’s Hospital of YibinYibin 644000China department of Gastrointestinal Surgery The Second Xiangya HospitalCentral South UniversityChangsha 410011China department of Anorectal Surgery First Affiliated HospitalZhengzhou UniversityZhengzhou 450052China department of Colorectal Cancer Surgery The Second Affiliated Hospital of Harbin Medical UniversityHarbin 150081China department of Gastrointestinal Surgery Affiliated Hospital of North Sichuan Medical CollegeNanchong 637000China department of Gastrointestinal Surgery Renji HospitalShanghai JiaoTong University School of MedicineShanghai 200240China department of Gastrointestinal Surgery Zhongshan Hospital of Xiamen UniversityXiamen 361004China department of General Surgery Xiangya HospitalCentral South UniversityChangsha 410008China department of General Surgery Xinqiao HospitalThird Military Medical UniversityChongqing 400037China department of Gastrointestinal Surgery Sichuan Cancer HospitalChengdu 610041China department of General Surgery Shandong University Qilu HospitalJinan 250012China department of Colorectal and Anal Surgery Shanxi Cancer HospitalTaiyuan 030013China department of Gastrointestinal Surgery The Affiliated Cancer Hospital of Guizhou Medical UniversityGuiyang 550008China department of General Surgery The First Affiliated Hospital of Nanchang UniversityNanchang 330006China department of Gastrointestinal Surgery Qinghai University Affiliated HospitalXining 810012China department of Gastrointestinal Surgery Fujian Medical University Cancer HospitalFuzhou 350014China Depar

经自然腔道取标本手术(NOSES)通过无切口理念与常规手术器械的结合,表现出极佳的微创效果,并带给患者全新的就医感受.目前,尽管NOSES已广泛用于结直肠肿瘤治疗,大量研究也表明相比常规腹腔镜手术,NOSES具有恢复快、创伤小、疼痛轻等优势... 详细信息

经自然腔道取标本手术(NOSES)通过无切口理念与常规手术器械的结合,表现出极佳的微创效果,并带给患者全新的就医感受.目前,尽管NOSES已广泛用于结直肠肿瘤治疗,大量研究也表明相比常规腹腔镜手术,NOSES具有恢复快、创伤小、疼痛轻等优势,但绝大多数研究均为小样本、单中心回顾性研究.本研究旨在通过分析我国5055例结直肠肿瘤NOSES患者数据,进一步探讨NOSES的短期疗效与预后.研究对象中,经直肠NOSES占整体比例的90.3%,经阴道NOSES占9.7%.NOSES术后短期并发症发生率为14.1%,吻合口瘘发生率为4.9%,腹盆腔感染率为1.9%.患者3年总生存率为93.2%,无病生存率为82.2%,局部复发率为3.6%.研究结果提示NOSES具有较好的安全性与可行性,为其应用于结直肠肿瘤治疗提供了证据.

关键词：结直肠肿瘤肿瘤学并发症发生率无病生存率吻合口瘘回顾性研究总生存率经直肠

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia(2021 Edition)

引用

Military Medical Research 2022年第5期9卷 515-533页

作者： Xian-Tao Zeng Ying-Hui Jin Tong-Zu Liu Fang-Ming Chen De-Gang Ding Meng Fu Xin-Quan Gu Bang-Min Han Xing Huang Zhi Hou Wan-Li Hu Xin-Li Kang Gong-Hui Li Jian-Xing Li Pei-Jun Li Chao-Zhao Liang Xiu-Heng Liu Zhi-Yu Liu Chun-Xiao Liu Jiu-Min Liu Guang-Heng Luo Yi Luo Wei-Jun Qin Jian-Hong Qiu Jian-Xin Qiu Xue-Jun Shang Ben-Kang Shi Fa Sun Guo-Xiang Tian Ye Tian Feng Wang Feng Wang Yin-Huai Wang Yu-Jie Wang Zhi-Ping Wang Zhong Wang Qiang Wei Min-Hui Xiao Wan-Hai Xu Fa-Xian Yi Chao-Yang Zhu Qian-Yuan Zhuang Li-Qun Zhou Xiao-Feng Zou Nian-Zeng Xing Da-Lin He Xing-Huan Wang 无 department of Urology Institute of UrologyZhongnan Hospital of Wuhan UniversityWuhan430071China Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan430071China department of Urology Tianjin Third Central Hospital Affiliated To Nankai UniversityTianjin300170China department of Urology Henan Provincial People’s HospitalZhengzhou University People’s HospitalZhengzhou450003China department of Urology Beijing Tsinghua Changgung HospitalSchool of Clinical MedicineTsinghua UniversityBeijing102218China department of Urology China-Japan Union Hospital of Jilin UniversityChangchun130033China department of Urology Shanghai General HospitalShanghai Jiao Tong University School of MedicineShanghai200080China department of Urology Qinghai University Affiliated HospitalXi’ning810012China department of Urology People’s Hospital of Hainan ProvinceHainan Affiliated Hospital of Hainan Medical University HaikouHaikou570311China department of Urology Sir Run Run Shaw HospitalZhejiang University School of MedicineHangzhou310016China department of Urology General Hospital of Ningxia Medical UniversityYinchuan750003China department of Urology The First Affiliated Hospital of Anhui Medical UniversityHefei230022China department of Urology Renmin Hospital of Wuhan UniversityWuhan430060China department of Urology The Second Hospital of Dalian Medical UniversityDalian116023LiaoningChina department of Urology Zhujiang Hospital of Southern Medical UniversityGuangzhou510282China department of Urology Guangdong Provincial People’s HospitalGuangdong Academy of Medical SciencesGuangzhou510080China department of Urology Surgery Guizhou Province People’s HospitalGuiyang550002China department of Urology Xijing Hospital of Air Force Military Medical UniversityXi’an710032China department of Urology The 980St Hospital of the PLA Joint Logistics Support Force(Bethune International Peace Hospital of PLA)Shijiazhuang050082China department of Urology

Benign prostatic hyperplasia (BPH) is highly prevalent among older men, impacting on their quality of life, sexual function, and genitourinary health, and has become an important global burden of disease. Transurethral plasmakinetic resection of prostate (TUPKP) is one of the foremost surgical procedures for the treatment of BPH. It has become well established in clinical practice with good efficacy and safety. In 2018, we issued the guideline “2018 Standard Edition”. However much new direct evidence has now emerged and this may change some of previous recommendations. The time is ripe to develop new evidence-based guidelines, so we formed a working group of clinical experts and methodologists. The steering group members posed 31 questions relevant to the management of TUPKP for BPH covering the following areas: questions relevant to the perioperative period (preoperative, intraoperative, and postoperative) of TUPKP in the treatment of BPH, postoperative complications and the level of surgeons’ surgical skill. We searched the literature for direct evidence on the management of TUPKP for BPH, and assessed its certainty generated recommendations using the grade criteria by the European Association of Urology. Recommendations were either strong or weak, or in the form of an ungraded consensus-based statement. Finally, we issued 36 statements. Among them, 23 carried strong recommendations, and 13 carried weak recommendations for the stated procedure. They covered questions relevant to the aforementioned three areas. The preoperative period for TUPKP in the treatment of BPH included indications and contraindications for TUPKP, precautions for preoperative preparation in patients with renal impairment and urinary tract infection due to urinary retention, and preoperative prophylactic use of antibiotics. Questions relevant to the intraoperative period incorporated surgical operation techniques and prevention and management of bladder explosion. The application to different

关键词： Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia Recommendation Treatment Guideline

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Value of Kidney Disease Improving Global Outcomes Urine Output Criteria in Critically III Patients： A Secondary Analysis of a Multicenter Prospective Cohort Study

引用

Chinese Medical Journal 2016年第17期129卷 2050-2057页

作者： Jun-Ping Qin Xiang-You Yu Chuan-Yun Qian Shu-Sheng Li Tie-He Qin Er-Zhen Chen Jian-Dong Lin Yu-Hang Ai Da-Wei Wu De-Xin Liu Ren-Hua Sun Zhen-Jie Hu Xiang-Yuan Cao Fa-Chun Zhou Zhen-Yang He Li-Hua Zhou You-Zhong An Yan Kang Xiao-Chun Ma Ming-Yan Zhao Li Jiang Yuan Xu Bin Du Medical Intensive Care Unit Peking Union Medical College Hospital Beijing 100730 China department of Critical Care Medicine Beijing Tongren Hospital Capital Medical University Beijing 100730 China department of Critical Care Medicine First Affiliated Hospital Xinjiang Medical University Urumqi Xinjiang 830054 China department of Emergency Medicine and Medical Intensive Care Unit The First Affiliated Hospital of Kunming Medical University Kunming Yunnan 650032 China department o1 Critical Care Medicine Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430030 China department of Critical Care Medicine Guangdong General Hospital Guangzhou Guangdong 510080 China department of Emergency Medicine Ruijin Hospital Shanghai Jiao Tong University Shanghai 200025 China department of Critical Care Medicine The First Affiliated Hospital of Fujian Medical University Fuzhou Fujian 350005 China department of Critical Care Medicine Xiangya Hospital Central South University Changsha Hunan 410008 China department of Critical Care Medicine Qilu Hospital Shandong University Jinan Shandong 250012 China department of Emergency and Critical Care Medicine The Second Hospital of Jilin University Changchun Jilin 130041 China department of Critical Care Medicine Zhejiang Provincial People's Hospital Hangzhou Zhejiang 310014 China department of Critical Care Medicine Hebei Medical University Fourth Hospital Shijiazhuang Hebei 050011 China department of Critical Care Medicine Affiliated Hospital of Ningxia Medical University Yinchuan Ningxia 750004 China department of Emergency and Intensive Care Medicine The First Affiliated Hospital Chongqing Medical University Chongqing 400016 China department of Critical Care Medicine Hainan Provincial People's Hospital Haikou Hainan 570311 China department of Critical Care Medicine The Affiliated Hospital of Inner Mongolia Medical College Hohhot Inner Mongolia 010050 China department of C

Background： Urine output （UO） is an essential criterion of the Kidney Disease Improving Global Outcomes （KD1GO） definition and classification system tbr acute kidney injury （AKI）, of which the diagnostic value has not been extensively studied. We aimed to determine whether AKI based on KDIGO UO criteria （KDtGOLro） could improve the diagnostic and prognostic accuracy, compared with KDIGO serum creatinine criteria （KDIGOscr）.Methods： We conducted a secondary analysis of the database of a previous study conducted by china Critical Care Clinical Trial Group （CCCCTG）, which was a 2-month prospective cohort study （July 1,2009 to August 31,2009） involving 3063 patients in 22 tertiary Intensive Care Units in Mainland of china. AKI was diagnosed and classified separately based on KDIGOt,o and KDlGOsc,. Hospital mortality of patients with more severe AKI classification based on KDIGOvo was compared with other patients by univariate and multivariate regression analyses. Results： The prevalence of AKl increased from 52.4. based on KDIGOscr to 55.4. based on KD1GOsc~ combined with KDIGOuo. KDIGOv~~ also restllted in an upgrade of AKI classification in 7.3% of patients, representing those with more severe AK1 classification based on KDIGOvo. Compared with non-AKI patients or those with maximum AKI classification by KDIGOscr, those with maximum AKI classification by KDIGOuo had a significantly higher hospital mortality of 58.4. （odds ratio [OR]： 7.580, 95% confidence interval [CI]： 4.14.-13.873, P 〈 0.001）. In a multivariate logistic regression analysis, AKI based on KDIGOuo （OR： 2.891, 95% CI： 1.964.4.254. P 〈 0.001）, but not based on KDIGOscr （OR： 1.322, 95% CI： 0.902-1.939, P = 0.152）, was an independent risk factor for hospital mortality. Conclusion： UO was a criterion with additional value beyond creatinine criterion for AKI diagnosis and classification, which can help identify a group of patients with high risk of death.

关键词： Acute Kidney Injury Critically Ill Mortality Serum Creatinine Urine Output

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

成人风湿免疫病患者新型冠状病毒疫苗接种及风险防控中国专家共识(2023版)

引用

中华风湿病学杂志 2023年第10期27卷 649-658页

作者：郑文洁张卓莉何岚李芬穆荣魏蔚武丽君谢其冰杨念生杨娉婷张文董凌莉赵岩中国初级卫生保健基金会风湿免疫学专业委员会中华医学会风湿病学分会中国医学科学院北京协和医学院北京协和医院风湿免疫科北京100730 北京大学第一医院风湿免疫科北京100034 西安交通大学第一附属医院风湿免疫科西安710061 中南大学湘雅二医院风湿免疫科长沙410011 北京大学第三医院风湿免疫科北京100191 天津医科大学总医院风湿免疫科天津300052 新疆维吾尔自治区人民医院风湿免疫科乌鲁木齐830001 四川大学华西医院风湿免疫科成都610000 中山大学附属第一医院风湿免疫科广州510080 中国医科大学附属第一医院风湿免疫科沈阳110001 华中科技大学同济医学院附属同济医院风湿免疫科武汉430030 不详

新型冠状病毒感染从2019年年底以来席卷全球, 给人类健康带来危害, 疫苗接种是预防新型冠状病毒感染和降低感染后重症化的有效手段。加快新型冠状病毒疫苗接种速度、扩大接种范围、提高全人群疫苗接种率已成为国际社会防控新型冠状病毒... 详细信息

新型冠状病毒感染从2019年年底以来席卷全球, 给人类健康带来危害, 疫苗接种是预防新型冠状病毒感染和降低感染后重症化的有效手段。加快新型冠状病毒疫苗接种速度、扩大接种范围、提高全人群疫苗接种率已成为国际社会防控新型冠状病毒蔓延的共识。风湿免疫病患者是罹患新型冠状病毒感染的高危人群, 该群体因疾病本身和长期用药往往处于免疫功能紊乱状态, 存在新型冠状病毒疫苗类型选择、使用方法、免疫应答减弱、突破性感染等一系列问题。本文基于国内外最新循证医学证据, 就成人风湿免疫病患者接种新型冠状病毒疫苗与新型冠状病毒预防的相关问题提出建议并形成专家共识, 以供临床医生及卫生保健人员参考。

关键词：风湿免疫病冠状病毒感染疫苗接种单克隆抗体

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

中国骨科手术加速康复围手术期氨甲环酸与抗凝血药应用的专家共识

引用

中华骨与关节外科杂志 2019年第2期12卷 81-88页

作者：中国康复技术转化及发展促进会中国研究型医院学会关节外科学专业委员会中国医疗保健国际交流促进会关节疾病防治分会国家卫生计生委公益科研专项《关节置换术安全性与效果评价》项目组周宗科黄泽宇杨惠林翁习生李庭王光林张志强刘涛陈允震沈慧勇吴新宝孙天胜唐佩福邱贵兴裴福兴不详解放军总医院第七医学中心骨科北京100700 中国人民解放军总医院骨科北京100853 四川大学华西医院骨科成都610041 苏州大学附属第一医院骨科江苏苏州215006 中国医学科学院北京协和医学院北京协和医院骨科北京100730 北京积水潭医院骨科北京100035 山西医科大学第二医院骨科太原030001 山东大学齐鲁医院青岛分院骨科青岛266000 山东大学齐鲁医院骨科济南250012 中山大学附属第八医院骨科广州510120

骨科手术出血量大,异体输血率高,极大增加了患者围手术期并发症和经济负担。氨甲环酸(TXA)是一种抗纤溶药物,大量研究均已证实其能有效减少骨科手术围手术期的失血量、降低输血率和并发症发生率。同时骨科大手术患者是静脉血栓栓塞症(V... 详细信息

骨科手术出血量大,异体输血率高,极大增加了患者围手术期并发症和经济负担。氨甲环酸(TXA)是一种抗纤溶药物,大量研究均已证实其能有效减少骨科手术围手术期的失血量、降低输血率和并发症发生率。同时骨科大手术患者是静脉血栓栓塞症(VTE)的高危人群,应用抗凝血药物能有效降低VTE的发生率。如何在骨科手术患者围手术期更好地应用抗纤溶药与抗凝血药,达到既可减少患者出血量、降低输血率,同时减少患者发生VTE的风险达到止血与抗凝的平衡,保障医疗安全。通过查阅文献,中国研究型医院学会关节外科学专业委员会和中国康复技术转化及发展促进会组织专家遵循循证医学原则,经过反复讨论和通讯修改,对骨科手术加速康复围手术期抗纤溶药与抗凝血药应用方案达成共识,供广大骨科医师在临床工作中参照应用。

关键词：骨科手术氨甲环酸抗凝血药加速康复

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Diagnosis and Treatment of Acne Inversa/Hidradenitis Suppurativa in china: An Expert Consensus Statement (2021 Version)

引用

International Journal of Dermatology and Venereology 2021年第2期4卷 100-108页

作者： Hong Fang Xing-Hua Gao Song-Mei Geng Heng Gu Jun Gu Li He Xian Jiang Hong-Zhong Jin Qiang Ju Xiao-Jing Kang Wei Lai Cheng-Xin Li Hang Li Heng-Jin Li Shan-Shan Li Yu-Zhen Li Qing Sun Juan Tao Baoxi Wang Gang Wang Xin-Feng Wu Lei-Hong Xiang Hong-Fu Xie Hao-Xiang Xu Jin-Hua Xu Yan Yan Zhi-Zhong Zheng department of Dermatology The First Affiliated Hospital of Zhejiang UniversityHangzhouZhejiang 310003China department of Dermatology No.1 Hospital of China Medical UniversityShenyangLiaoning 110001China department of Dermatology The Second Affiliated Hospital of Xi’an Jiaotong UniversityXi’anShaanxi 710061China Hospital for Skin Diseases(Institute of Dermatology) Chinese Academy of Medical Sciences and Peking Union Medical CollegeNanjingJiangsu 210042China department of Dermatology Shanghai Tenth People’s HospitalTongji University School of MedicineShanghai 200072China department of Dermatology First Affiliated Hospital of Kunming Medical UniversityKunmingYunnan 650032China department of Dermatology West China HospitalSichuan UniversityChengduSichuan 610041China department of Dermatology Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China department of Dermatology Renji HospitalSchool of MedicineShanghai Jiaotong UniversityShanghai 200025China department of Dermatology People’s Hospital of Xinjiang Uygur Autonomous RegionUrumqiXinjiang 830001China department of Dermatology and Venereology The Third Affiliated HospitalSun Yat-sen UniversityGuangzhouGuangdong 510630China department of Dermatology First Medical Center of Chinese PLA General HospitalBeijing 100853China department of Dermatology and Venerology Peking University First HospitalBeijing 100034China department of Dermatology Hainan Hospital of PLA General HospitalSanyaHainan 572013China department of Dermatology and Venereology The First Hospital of Jilin UniversityChangchunJilin 130021China department of Dermatology Second Affiliated Hospital of Harbin Medical UniversityHarbinHeilongjiang 150086China department of Dermatology Qilu Hospital of Shandong UniversityJinanShandong 250012China department of Dermatology Affiliated Union HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhanHubei 430022China De

Acne inversa/hidradenitis suppurativa is a chronic,recurrent,inflammatory skin disease that affects the pilosebaceous units,causinfollicular *** etiology and pathogenesis of acne inversa/hidradenitis suppurativa involves internal and external factors such as genetic susceptibility,inflammation and immunity,microorganisms,obesity,and *** inversa/hidradenitis suppurativa is difficult to treat,and the current aim of treatment is to control the frequency and duration of disease flares and improve the quality of *** protocols for acne inversa/hidradenitis suppurativa should be selected based on the disease severity *** treatments include antibiotics,retinoids,biologics,immunosuppressive agents,and antiandrogen *** treatments include surgery and laser/light *** consensus aims to further standardize the diagnosis and treatment procedures of acne inversa/hidradenitis suppurativa in china to facilitate its diagnosis and treatment.

关键词： acne inversa consensus diagnosis hidradenitis suppurativa therapy

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

腓骨肌萎缩症外科治疗专家共识

引用

中华骨与关节外科杂志 2022年第9期15卷 641-651页

作者：中华医学会骨科学分会足踝外科学组国际矫形与创伤外科学会中国部足踝外科学会中国医疗保健国际交流促进会骨科分会足踝外科学部中国研究型医院学会足踝医学专业委员会中国医师协会骨科医师分会足踝外科、基础研究与矫形学组王正义俞光荣张建中徐向阳李开南唐康来马昕胡勇陈兆军梁晓军苗旭东王旭宋卫东张奉琪徐海林武勇张晖高鹏曾参军曾宪铁钱敏祁印泽不详北京中医药大学第三附属医院骨科北京100029 同济大学附属同济医院骨科上海200065 首都医科大学附属北京同仁医院骨科北京100730 上海交通大学医学院附属瑞金医院骨科上海200025 成都大学附属医院骨科成都610081 陆军军医大学第一附属医院骨科重庆400038 复旦大学附属华山医院骨科上海200040 山东大学第二医院骨科济南250033 西安交通大学医学院附属红会医院骨科西安710000 浙江大学医学院附属第二医院骨科杭州310009 中山大学孙逸仙纪念医院骨科广州510120 河北医科大学第三医院骨科石家庄050051 北京大学人民医院骨科北京100044 北京积水潭医院骨科北京100035 四川大学华西医院骨科成都610041 中国医学科学院北京协和医学院北京协和医院骨科北京100730 南方医科大学第三附属医院骨科广州510630 天津大学天津医院骨科天津300211 中国医学科学院北京协和医学院北京协和医院神经科北京100730

腓骨肌萎缩症在我国已确定为罕见病。由于该病较为罕见,国内骨科界对其认识参差不齐,外科治疗缺乏循证医学的指导意见,欠缺规范化。为更好地认识与治疗该病,避免其并发症的发生,同时为获得更好的疗效,中华医学会骨科学分会足踝外科学组... 详细信息

腓骨肌萎缩症在我国已确定为罕见病。由于该病较为罕见,国内骨科界对其认识参差不齐,外科治疗缺乏循证医学的指导意见,欠缺规范化。为更好地认识与治疗该病,避免其并发症的发生,同时为获得更好的疗效,中华医学会骨科学分会足踝外科学组,国际矫形与创伤外科学会中国部足踝外科学会,中国医疗保健国际交流促进会骨科分会足踝外科学部,中国研究型医院学会足踝医学专业委员会,中国医师协会骨科医师分会足踝外科、基础研究与矫形学组联合邀请国内知名专家,参考国内外相关的最新研究成果,研究探讨了该病的病理特点、病程发展规律、检查流程与诊断标准,提出外科治疗的策略与方法,最终形成本共识,以促进我国在该领域的进一步研究和提高腓骨肌萎缩症的诊疗水平。

关键词：腓骨肌萎缩症共识外科治疗

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline(updated version)

引用

Military Medical Research 2020年第3期7卷 249-282页

作者： Ying-Hui Jin Qing-Yuan Zhan Zhi-Yong Peng Xue-Qun Ren Xun-Tao Yin Lin Cai Yu-Feng Yuan Ji-Rong Yue Xiao-Chun Zhang Qi-Wen Yang Jianguang Ji Jian Xia Yi-Rong Li Fu-Xiang Zhou Ya-Dong Gao Zhui Yu Feng Xu Ming-Li Tu Li-Ming Tan Min Yang Fang Chen Xiao-Ju Zhang Mei Zeng Yu Zhu Xin-Can Liu Jian Yang Dong-Chi Zhao Yu-Feng Ding Ning Hou Fu-Bing Wang Hao Chen Yong-Gang Zhang Wei Li Wen Chen Yue-Xian Shi Xiu-Zhi Yang Xue-Jun Wang Yan-Jun Zhong Ming-Juan Zhao Bing-Hui Li Lin-Lu Ma Hao Zi Na Wang Yun-Yun Wang Shao-Fu Yu Lu-Yao Li Qiao Huang Hong Weng Xiang-Ying Ren Li-Sha Luo Man-Ru Fan Di Huang Hong-Yang Xue Lin-Xin Yu Jin-Ping Gao Tong Deng Xian-Tao Zeng Hong-Jun Li Zhen-Shun Cheng Xiao-Mei Yao Xing-Huan Wang Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for Respiratory Diseases China-Japan Friendship HospitalBeijing 100029China department of Pulmonary and Critical Care Medicine China-Japan Friendship HospitalBeijing 10029China Leishenshan Hospital in Wuhan Wuhan 430200China department of Critical Care Medicine Zhongnan Hospital of Wuhan UniversityWuhan 430071China Institutes of Evidence-based Medicine and Knowledge Translation Henan UniversityKaifeng 475000HenanChina department of Medical Imaging Guizhou Provincial People’s HospitalGuiyang 550002China departments of Orthopedics Zhongnan Hospital of Wuhan UniversityWuhan 430071China department of Hepatobiliary Surgery Zhongnan Hospital of Wuhan UniversityWuhan 430071China National Clinical Research Center for Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China department of Geriatrics West China Hospital of Sichuan UniversityChengdu 610041China department of Radiology Zhongnan Hospital of Wuhan UniversityWuhan 430071China department of Clinical Laboratory Peking Union Medical College Hospital(PUMCH)Peking Union Medical CollegeChinese Academy of Medical Sciences(CAMS)Beijing 100730China Center for Primary Health Care Research Lund University and Region Skåne25002 MalmöSweden Emergency Center Zhongnan Hospital of Wuhan UniversityWuhan 403371China department of Allergology Zhongnan Hospital of Wuhan UniversityWuhan 430071China department of Radiation and Medical Oncology Zhongnan Hospital of Wuhan UniversityWuhan 43071China department of Critical Care Medicine Renmin Hospital of Wuhan UniversityWuhan 430060China department of Emergency Medicine and Chest Pain Center Qilu Hospital of Shandong UniversityJinan 250002China department of Respiratory and Critical Care Medicine Suizhou Central HospitalHubei University of MedicineSuizhou 441300HubeiChina department of Clinic Pharmacy Second People’s Hospital of Huaihua Ci

The novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is the cause of a rapidly spreading illness,coronavirus disease 2019(COVID-19),affecting more than seventeen million people around the *** and treatment guidelines for clinicians caring for patients are *** the early stage,we have issued"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus(2019-nCoV)infected pneumonia(standard version)";now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based *** formed a working group of clinical experts and *** steering group members proposed 29 questions that are relevant to the management of COVID-19 covering the following areas:chemoprophylaxis,diagnosis,treatments,and discharge *** searched the literature for direct evidence on the management of COVID-19,and assessed its certainty generated recommendations using the Grading of Recommendations,Assessment,Development and Evaluation(GRADE)*** were either strong or weak,or in the form of ungraded consensus-based ***,we issued 34.*** them,6 were strong recommendations for,14.were weak recommendations for,3 were weak recommendations against and 11 were ungraded consensus-based *** covered topics of chemoprophylaxis(including agents and Traditional Chinese Medicine(TCM)agents),diagnosis(including clinical manifestations,reverse transcription-polymerase chain reaction(RT-PCR),respiratory tract specimens,IgM and IgG antibody tests,chest computed tomography,chest X-ray,and CT features of asymptomatic infections),treatments(including lopinavirritonavir,umifenovir,favipiravir,interferon,remdesivir,combination of antiviral drugs,hydroxychloroquine/chloroquine,interleukin-6 inhibitors,interleukin-1 inhibitors,glucocorticoid,qingfei paidu decoction,lianhua qingwen granules/capsules,convalescent plasma,lung

关键词： COVID-19 SARS-CoV-2 Recommendation Chemoprophylaxis Diagnosis Treatment Discharge management Traditional Chinese medicine guideline

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

ERAS理念下踝关节骨折诊疗方案优化的专家共识

引用

中华骨与关节外科杂志 2019年第1期12卷 3-12页

作者：白求恩公益基金会创伤骨科专业委员会中国医疗保健国际交流促进会加速康复外科学分会创伤骨科学组李庭孙志坚柴益民张堃东靖明孙旭周雁赵霞米萌肖鸿鹄王京翟建坡王倩李旭高志强彭贵凌王爱国刘利民胡三保王剑芮云峰吴新宝余斌裴福兴田伟高鹏刘璠姜保国唐佩福王满宜李宁张英泽邱贵兴不详北京积水潭医院康复科北京100035 郑州市骨科医院骨科郑州450052 首都医科大学附属宣武医院骨科北京100053 首都医科大学附属北京安贞医院骨科北京100029 北京市房山区第一医院骨科北京102400 东南大学附属中大医院骨科南京210009 南方医科大学南方医院创伤骨科广州510515 四川大学华西医院骨科成都610041 北京积水潭医院脊柱外科北京100035 中国医学科学院北京协和医学院北京协和医院骨科北京100730 北京积水潭医院创伤骨科北京100035 南通大学附属医院骨科江苏南通226001 北京大学人民医院创伤骨科北京100044 解放军总医院骨科北京100853 同济大学附属第十人民医院结直肠病专科上海200072 河北医科大学第三医院创伤急救中心石家庄050051 上海交通大学附属第六人民医院骨科上海200233 西安市红十字会医院创伤骨科西安710054 天津医院骨科天津300211 北京积水潭医院麻醉科北京100035 北京积水潭医院营养科北京100035 北京积水潭医院泌尿外科北京100035 北京积水潭医院内分泌科北京100035

踝关节骨折是创伤骨科常见骨折之一。通过引入加速康复外科(enhanced recovery after surgery,ERAS)理念,对围手术期处理措施进行全面优化,可以进一步提高患者诊疗效果。为规范ERAS临床路径在踝关节骨折中的应用,基于前期研究经验,以循... 详细信息

踝关节骨折是创伤骨科常见骨折之一。通过引入加速康复外科(enhanced recovery after surgery,ERAS)理念,对围手术期处理措施进行全面优化,可以进一步提高患者诊疗效果。为规范ERAS临床路径在踝关节骨折中的应用,基于前期研究经验,以循证医学证据为依据,经过全国专家组反复讨论,编制该专家共识,供全国创伤骨科医师在临床工作中参考。该共识适用于所有进行择期手术治疗的成人新鲜踝关节骨折患者。共识共包含25条推荐意见,就踝关节骨折患者急诊处理、术前准备、术中处理以及术后恢复进行了全面介绍。

关键词：加速康复外科踝关节骨折专家共识围手术期处理

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Search for the weak decayψ(3686)→■+c.c.

引用

Chinese physics C 2023年第1期47卷 19-27页

作者：麦迪娜 M.N.Achasov P.Adlarson M.Albrecht R.Aliberti A.Amoroso 安美儒安琪白旭红白羽 O.Bakina R.Baldini Ferroli I.Balossino 班勇 V.Batozskaya D.Becker K.Begzsuren N.Berger M.Bertani D.Bettoni F.Bianchi J.Bloms A.Bortone I.Boyko R.A.Briere A.Brueggemann 蔡浩蔡啸 A.Calcaterra 曹国富曹宁 S.A.Cetin 常劲帆常万玲 G.Chelkov 陈琛陈超陈刚陈和生陈玛丽陈申见陈少敏 T.Chen 陈旭荣 X.T.Chen 陈元柏陈卓俊成伟帅初晓 G.Cibinetto F.Cossio 崔佳佳代洪亮代建平 A.Dbeyssi R.E.de Boer D.Dedovich 邓子艳 A.Denig I.Denysenko M.Destefanis F.De Mori 丁勇董静董燎原董明义董翔杜书先 P.Egorov 范玉兰方建房双世方文兴方易 R.Farinelli L.Fava F.Feldbauer G.Felici 封常青冯俊华 K Fischer M.Fritsch C.Fritzsch 傅成栋高涵高原宁高扬 S.Garbolino I.Garzia 葛潘婷葛振武耿聪 E.M.Gersabeck A Gilman K.Goetzen 龚丽龚文煊 W.Gradl M.Greco 谷立民顾旻皓顾运厅关春懿郭爱强郭立波郭如盼郭玉萍 A.Guskov 韩婷婷韩文颖郝喜庆 F.A.Harris 何凯凯何康林 F.H.Heinsius C.H.Heinz 衡月昆 C.Herold M.Himmelreich 侯国一侯颖锐侯治龙胡海明 J.F.Hu 胡涛胡誉黄光顺黄凯旋黄麟钦黄麟钦黄性涛黄燕萍黄震 T.Hussain N Hüsken W.Imoehl M.Irshad J.Jackson S.Jaeger S.Janchiv 纪全姬清平季晓斌季筱璐吉钰瑶贾泽坤姜侯兵姜赛赛江晓山 Y.Jiang 焦健斌焦铮金山金毅荆茂强 T.Johansson N.Kalantar-Nayestanaki 康晓珅 R.Kappert 柯百谦 I.K.Keshk A.Khoukaz P.Kiese R.Kiuchi R.Kliemt L.Koch O.B.Kolcu B.Kopf M.Kuemmel M.Kuessner A.Kupsc W.Kühn J.J.Lane J.S.Lange P.Larin A.Lavania L.Lavezzi 雷祚弘 H.Leithoff M.Lellmann T.Lenz 李翠李聪李春花李澄李德民李飞李刚李慧李贺李海波李惠静 H.N.Li J.Q.Li 李静舒李井文李科 L.J.Li 李龙科李蕾李明浩李培荣李素娴栗帅迎李腾李卫东李卫国李旭红李晓玲李晓宇梁昊梁浩梁浩梁勇飞梁羽铁廖广睿廖龙洲 J.Libby A.Limphirat 林创新林德旭 T.Lin 刘北江刘春秀 D.Liu 刘福虎刘芳刘峰 G.M.Liu H.Liu 刘宏邦刘怀民刘欢欢刘汇慧刘建北刘佳俊刘晶译刘凯刘魁勇刘珂刘亮刘露刘美宏刘佩莲刘倩刘树彬刘桐刘维克刘卫民刘翔刘英刘玉斌刘振安刘智青娄辛丑卢飞翔吕海江吕军光陆小玲卢宇卢云鹏 Z.H.Lu 罗成林罗民兴罗涛罗小兰吕晓睿吕翌丰马凤才马海龙马连良马明明马秋梅马润秋马瑞廷马骁妍马尧 F.E.Maas M.Maggiora S.Maldaner S.Malde Q.A.Malik A.Mangoni 冒亚军毛泽普 S.Marcello 孟召霞 J.G.Messchendorp G.Mezzadri H.Miao 闵天觉 R.E.Mitchell 莫晓虎 N.Yu.Muchnoi Y.Nefedov F.Nerling I.B.Nikolaev 宁哲 S.Nisar 牛艳 S.L.Olsen 欧阳群 S.Pacetti 潘祥潘越 A.Pathak M.Pelizaeus 彭海平 K.Peters 平加伦平荣刚 S.Plura S.Pogodin V.Prasad 齐法制齐航漆红荣祁鸣齐天钰钱森钱文斌钱圳乔从丰秦佳佳秦丽清覃潇平秦小帅秦中华邱进发屈三强 K.H.Rashid C.F.Redmer 任旷洁 A.Rivetti V.Rodin M.Rolo 荣刚 Ch.Rosn Institute of High Energy physics Beijing 100049China Beihang university Beijing 100191China Beijing Institute of Petrochemical Technology Beijing 102617China Bochum Ruhr-university D-44780 BochumGermany Carnegie Mellon university PittsburghPennsylvania 15213USA Central china Normal university Wuhan 430079China Central South university Changsha 410083China china Center of Advanced Science and Technology Beijing 100190China COMSATS university Islamabad Lahore CampusDefence RoadOff Raiwind Road54000 LahorePakistan Fudan university Shanghai 200433China G.I.Budker Institute of Nuclear physics SB RAS(BINP) Novosibirsk 630090Russia GSI Helmholtzcentre for Heavy Ion Research GmbH D-64291 DarmstadtGermany Guangxi Normal university Guilin 541004China Guangxi university Nanning 530004China Hangzhou Normal university Hangzhou 310036China Hebei university Baoding 071002China Helmholtz Institute Mainz Staudinger Weg 18D-55099 MainzGermany Henan Normal university Xinxiang 453007China Henan university of Science and Technology Luoyang 471003China Henan university of Technology Zhengzhou 450001China Huangshan College Huangshan 245000China Hunan Normal university Changsha 410081China Hunan university Changsha 410082China Indian Institute of Technology Madras Chennai 600036India Indiana university BloomingtonIndiana 47405USA AINFN Laboratori Nazionali di Frascati I-00044FrascatiItaly INFN Sezione di Perugia I-06100PerugiaItaly university of Perugia I-06100PerugiaItaly INFN Sezione di Ferrara I-44122FerraraItaly university of Ferrara I-44122FerraraItaly Institute of Modern physics Lanzhou 730000China Institute of physics and Technology Peace Avenue 54BUlaanbaatar 13330Mongolia Jilin university Changchun 130012China Johannes Gutenberg university of Mainz Johann-Joachim-Becher-Weg 45D-55099 MainzGermany Joint Institute for Nuclear Research 141980 DubnaMoscow regionRussia Justus-Liebig-Universitaet Giessen II.Physikalisches InstitutHeinrich-Buff-Ring 16D-35392 GiessenGermany Lanzhou U

Using(4.8.1±2.9)×10^(6)ψ(3686)for the weak baryonic decayψ(3686)→Λc+∑-+c.c..The analysis procedure is optimized using a blinded *** significant signal is observed,and the upper limit on the branching fraction(B... 详细信息

关键词： weak decay upper limit BESIII detector

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：